Clinical Trials Browser

Phase 1/2 × NIH × MART-1 Antigen × Clear all

NCT00010309 2014-01-06

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma

NCT00019214 2013-06-20

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 1/2 Completed

Melanoma